Healtcare Active Pharmaceutical Ingredients Market

Active Pharmaceutical Ingredients Market – Global Industry Insights,
Trends, Outlook, and Opportunity Analysis, 2018-2026
Active Pharmaceutical Ingredients (API) are active constituents used in the manufacturing of
pharmaceutical formulations and have a pharmacological and therapeutic effects on the body. API
constitutes the main ingredient, which helps cure the disease or disorder. APIs provide health
benefits and are used in disease diagnosis, prevention, and treatment. APIs cannot be used in the
raw form because it is the crude form of drug, which will not meet the appropriate
pharmacodynamics and pharmacokinetics parameters. APIs are thus combined with the suitable
excipients which are pharmacologically and therapeutically inactive but enhance its stability and
activities.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/738
Increasing prevalence of chronic diseases is expected to boost the active pharmaceutical
ingredients market over the forecast period
According to World Health Organization (WHO), mortality and global health estimates of 2015,
Ischaemic heart disease, stroke, chronic obstructive lung disease, and lower respiratory infections
have been the cause for maximum number of deaths during the past decade. Diabetes caused 1.6
million (2.8%) deaths in 2015, from 1.0 million (1.8%) deaths in 2000. Deaths due to dementias
doubled between 2000 and 2015, making it the 7th leading cause of global deaths in 2015. The
increasing prevalence of chronic diseases is expected to increase the demand for drugs, in turn
fueling the active pharmaceutical ingredients market in the near future.
Cumulative prevalence of non-communicable diseases in Africa is expected to fuel the active
pharmaceutical ingredients market over the forecast period
Regional market for active pharmaceutical ingredients by Coherent Market Insights, is segmented
into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Africa is
expected to hold a dominant position in the active pharmaceutical ingredients market in the future
due to the increasing prevalence of non-communicable diseases in the region. According to WHO,
2015, NCD deaths are projected to increase by 15% globally, between 2010 and 2020. The Asia
Pacific region is expected to be the fastest emerging region in the Active Pharmaceutical Ingredients
Market owing to the increasing consumption of tobacco, alcohol, unhealthy diet, and physical
inactivity observed among the populace, which are expected to cause chronic diseases.
Government plans bulk drugs parks, import curbs to boost manufacturing in India